课题基金 / 基金详情

KFO 249: Defects of the Innate Immune System in Autoinflammation and Autoimmunity

KFO 249: Defects of the Innate Immune System in Autoinflammation and Autoimmunity
KFO 249:先天免疫系统在自身炎症和自身免疫中的缺陷
批准号:
160548243
负责人:
金额:
$0.0万
依托单位国家:
德国
项目类别:
Clinical Research Units
财政年份:
2010
资助国家:
德国
项目状态:
已结题
起止时间:
2009-12-31 至 2018-12-31

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The innate immune system plays a central role in defending microorganisms and in dealing with inflammatory processes. The Clinical Research Unit focusses on identifying new pathophysiological mechanisms of hereditary diseases caused by defects in the innate immune system. The phenotypic spectrum of the disorders analysed includes periodic fever, cutane and systemic variants of lupus erythematosus as well as the Aicardi-Goutières syndrome, an autoimmunity-related encephalopathy. A common characteristic of these diseases is the fact that their underlying genetic changes point to so far unknown mechanisms in relation to the innate immune system. On the basis of genetically determined autoinflammatory and autoimmunological disorders, the effects of mutations in genes of the innate immune system will be analysed by eight subgroups of the Clinical Research Unit at the molecular and cellular level as well as in animal models and in patients. Furthermore, the scientists will correlate effects of genetic mutations with clinical data. The expected results are supposed to provide fundamental insights into the molecular pathogenesis of defects occurring in the innate immune system. In addition, the findings shall support the development of clinical therapies. In this regard, the gene products, their interaction partners and the signalling pathways involved do not only represent the basis for improved diagnostic possibilities. Moreover, they are potential target molecules, which can essentially contribute to the development of new causally oriented therapy approaches.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
p53 R249S在人胚胎干细胞向肝细胞定向分化中异常活化FOXM1/PGK1介导糖代谢重编程促进肝细胞癌发生的作用及机制研究
  • 批准号:
    82002510
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    24.0万元
  • 批准年份:
    2020
  • 负责人:
    霍梓君
  • 依托单位:
基于TP53 R249S生物标签的肝癌循环肿瘤DNA检测新技术构建的实验研究
  • 批准号:
    81601860
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    17.0万元
  • 批准年份:
    2016
  • 负责人:
    陈栋
  • 依托单位:
对虾白斑综合症病毒泛素连接酶WSV249的功能及转录调控研究
p53 249 突变Knock-in 动物模型的建立及其在肝癌发病中的作用